Abstract Details
| No disclosure on file | |
| Ugonma N. Chukwueke, MD (Dana-Farber Cancer Institute) | Dr. Chukwueke has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Mark W. Jacobson, PhD | No disclosure on file |
| Guerry M. Peavy, PhD (University of California, San Diego) | Dr. Peavy has stock in MRK. Dr. Peavy has stock in ABT. Dr. Peavy has stock in JNJ. Dr. Peavy has stock in ABBV. The institution of an immediate family member of Dr. Peavy has received research support from NIH. The institution of Dr. Peavy has received research support from NIH. |
| Jody Corey-Bloom, MD, PhD, FAAN (UCSD Neurosciences) | Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Corey-Bloom has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticaks. Dr. Corey-Bloom has received personal compensation in the range of $10,000-$49,999 for serving as a Co-Director, HD-Net with Huntington Study Group. |
| No disclosure on file | |
| No disclosure on file |